Opinion
Editor’s note: The Alliance for a Stronger FDA recently offered this analysis of the Food and Drug Administration’s FY 2021 funding.
The current fiscal year (FY) 2021 Continuing Resolution runs through Dec. 11. So either (1) action on funding bills will be completed by that date, (2) another short
Continue Reading Continuing funding for FDA complicated by congressional options